Peer-reviewedCC BY-NC-NDCirculation Journal
Changes in Remote Monitoring for Patients With Cardiac Implantable Electronic Devices After a Reimbursement Revision ― An Interrupted Time-Series Analysis ―
Abstract
BACKGROUND: Remote monitoring (RM) enables early detection of abnormalities in cardiac implantable electronic devices (CIED), but implementation remains suboptimal. METHODS AND RESULTS: We analyzed 396,296 patients hospitalized for CIED implantation and evaluated changes after RM reimbursement revision using an interrupted time-series analysis. The proportion increased by 4.89% (95% confidence interval [CI]: 3.71 to 6.06%) in the pacemaker implantation cohort, but no significant increase was observed in the implantable cardioverter defibrillator and cardiac resynchronization therapy cohort (0.79%; 95% CI: -1.12 to 2.71%). CONCLUSIONS: The effect of reimbursement policy changes on RM adoption may differ according to the type of CIED.
Related
- Increase in Reimbursement Does Not Necessarily Place a Financial Burden on Patients ― Background Behind the Reimbursement Revision for Remote Monitoring of Cardiac Implantable Electronic Devices in Japan ―
- The impact of remote monitoring on clinical outcomes in defibrillator patients during the COVID-19 pandemic: An interrupted time series analysis
- TricValve System Implantation in Patients With Cardiac Implantable Electronic Devices: A Multicentre Observational Study
- Trajectory changes in psychosocial adaptation levels of patients after implantation of cardiac implantable electronic devices and development of the intervention programme: a mixed-methods research protocol
- The hidden pause: Filtering of true prolonged asystole in implantable loop recorder monitoring platform by artificial intelligence.
BibTeX
@article{takegawa2026changes,
title = {{Changes in Remote Monitoring for Patients With Cardiac Implantable Electronic Devices After a Reimbursement Revision ― An Interrupted Time-Series Analysis ―}},
author = {Koki Takegawa and Koshiro Kanaoka and Haruka Matsuura and Shoko Chishaki-Kawabata and Yoshitaka Iwanaga and Tetsuo Sasano and Yoshihiro Miyamoto},
journal = {Circulation Journal},
year = {2026},
month = aug,
doi = {10.1253/circj.cj-26-0548},
url = {https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-26-0548/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Changes in Remote Monitoring for Patients With Cardiac Implantable Electronic Devices After a Reimbursement Revision ― An Interrupted Time-Series Analysis ―
AU - Koki Takegawa
AU - Koshiro Kanaoka
AU - Haruka Matsuura
AU - Shoko Chishaki-Kawabata
AU - Yoshitaka Iwanaga
AU - Tetsuo Sasano
AU - Yoshihiro Miyamoto
PY - 2026
DA - 2026/08/29
JO - Circulation Journal
DO - 10.1253/circj.cj-26-0548
UR - https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-26-0548/_article
AB - BACKGROUND: Remote monitoring (RM) enables early detection of abnormalities in cardiac implantable electronic devices (CIED), but implementation remains suboptimal. METHODS AND RESULTS: We analyzed 396,296 patients hospitalized for CIED implantation and evaluated changes after RM reimbursement revision using an interrupted time-series analysis. The proportion increased by 4.89% (95% confidence interval [CI]: 3.71 to 6.06%) in the pacemaker implantation cohort, but no significant increase was observed in the implantable cardioverter defibrillator and cardiac resynchronization therapy cohort (0.79%; 95% CI: -1.12 to 2.71%). CONCLUSIONS: The effect of reimbursement policy changes on RM adoption may differ according to the type of CIED.
SN - 1347-4820
SN - 1346-9843
ER -